Allison Humphries's Publications
About Allison Humphries's Publications
Senior Research Fellow, Respiratory Programme- Operations Lead, Academic Project Operations
-
Serum Adiponectin Levels in Normal and Hypertensive Pregnancy
Hypertension in Pregnancy Date published: -
Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trial
AIDS Date published: -
Therapeutic approaches to combating lipoatrophy: do they work?
Journal of Antimicrobial Chemotherapy Date published: -
Influence of Rosiglitazone on Flow-Mediated Dilation and Other Markers of Cardiovascular Risk in HIV-Infected Patients with Lipoatrophy
Antiviral Therapy Date published: -
Progression of Lipodystrophy (LD) with Continued Thymidine Analogue Usage: Long-Term Follow-Up from a Randomized Clinical Trial (The PIILR Study)
HIV Clinical Trials Date published: -
Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir
AIDS Date published: -
No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial
The Lancet Date published: -
Progression of lipodystrophy (LD) with continued thymidine analogue usage; long-term follow up of a randomized clinical trial (The PIILR study).
HIV Clinical Trials Date published: -
Reversibility of lipoatrophy in HIV infected patients after switching from a thymidine analogue to abacavir
AIDS Date published: -
Rosiglitazone for HIV lipoatrophy: 84 weeks follow-up
Antiviral Therapy Date published: -
No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.
Lancet Date published: -
Centralized Assessment of Dual-Energy X-ray Absorptiometry (DEXA) in Multicenter Studies of HIV-Associated Lipodystrophy
HIV Clinical Trials Date published: -
The Lipodystrophy Syndrome.
HIV Australia Date published: -
Centralized Assessment of Dual-Energy X-ray Absorptiometry (DEXA) in Multicenter Studies of HIV-Associated Lipodystrophy
HIV Research & Clinical Practice Date published: -
Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control
AIDS Date published: -
Abacavir Substitution for Nucleoside Analogs in Patients With HIV Lipoatrophy A Randomized Trial
JAMA Date published: